Cargando…

Effect of high-fat diet and empagliflozin on cardiac proteins in mice

Using proteomic techniques the impact of the sodium-glucose transport protein 2 inhibitor empagliflozin on cardiac protein expression in a mouse model was assessed under normal and high-fat diet (HFD) conditions. We examined the effect of obesity on serological markers and heart function in obese mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Xiaoyu, Chen, Shuchun, Chen, Xing, Ren, Qingjuan, Yue, Lin, Niu, Shu, Li, Zelin, Zhu, Ruiyi, Chen, Xiaoyi, Jia, Zhuoya, Zhen, Ruoxi, Ban, Jiangli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563173/ https://www.ncbi.nlm.nih.gov/pubmed/36242090 http://dx.doi.org/10.1186/s12986-022-00705-0

Ejemplares similares

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
por: Chen, Xing, et al.
Publicado: (2022)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
por: Yue, Lin, et al.
Publicado: (2022)

Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
por: Pan, Xiaoyu, et al.
Publicado: (2023)

The Relationship Between Non-HDL-C /HDL-C Ratio (NHHR) and Vitamin D in Type 2 Diabetes Mellitus
por: Zhen, Ruoxi, et al.
Publicado: (2023)

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
por: Ren, Qingjuan, et al.
Publicado: (2022)

Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy
por: Ban, Jiangli, et al.
Publicado: (2023)

Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Association Between Vitamin D Levels and the Atherogenic Index of Plasma Among Chinese with Type 2 Diabetes Mellitus
por: Ban, Jiangli, et al.
Publicado: (2023)

Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Effect of empagliflozin on cytoskeletal repair in the hippocampus of obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2022)

The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus
por: Li, Zelin, et al.
Publicado: (2022)

Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy
por: Chen, Xing, et al.
Publicado: (2022)

Association of Triglyceride-Glucose Index and Liver Function Parameters Among Healthy Obese Civil Servants: A Center-Based Study
por: Pan, Xiaoyu, et al.
Publicado: (2022)

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study
por: Pan, Xiaoyu, et al.
Publicado: (2023)

Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice
por: Chen, Xiaoyi, et al.
Publicado: (2023)

Correlation of Obesity and Overweight with Cervical Vascular Function Among Healthy Populations
por: Pan, Xiaoyu, et al.
Publicado: (2022)

The Combination of Remnant Cholesterol and Waist Circumference Offers Predictive Value for Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Medical Examination Center
por: Jia, Zhuoya, et al.
Publicado: (2023)

Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
por: Wang, Xing, et al.
Publicado: (2021)

The Ratio of Fibrinogen to Albumin is Related to the Occurrence of Retinopathy in Type 2 Diabetic Patients
por: Chen, Xiaoyi, et al.
Publicado: (2023)

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
por: Xu, Liang, et al.
Publicado: (2019)

Proteomic analysis reveals semaglutide impacts lipogenic protein expression in epididymal adipose tissue of obese mice
por: Zhu, Ruiyi, et al.
Publicado: (2023)

An attempt to reverse cardiac lipotoxicity by aerobic interval training in a high-fat diet- and streptozotocin-induced type 2 diabetes rat model
por: Cai, Huan, et al.
Publicado: (2019)

Predictive Value of Plasma Atherogenic Index for Microalbuminuria in Newly Diagnosed Patients with Type 2 Diabetes Mellitus
por: Qi, Licui, et al.
Publicado: (2022)

Integrated multi-omics analyses reveal effects of empagliflozin on intestinal homeostasis in high-fat-diet mice
por: Shi, Junfeng, et al.
Publicado: (2022)

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
por: Chen, Sha, et al.
Publicado: (2023)

Empagliflozin: Novel antidiabetes and pro-cardiac drug
por: Raut, Monish S, et al.
Publicado: (2017)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice
por: Xie, Bingxian, et al.
Publicado: (2022)

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
por: Xu, Liang, et al.
Publicado: (2017)

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
por: Zou, Rongjun, et al.
Publicado: (2022)

Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis
por: Chung, Cheng-Chih, et al.
Publicado: (2023)

Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Song, Tiantian, et al.
Publicado: (2021)

Correlation Between Hemoglobin Glycosylation Index and Nerve Conduction Velocity in Patients with Type 2 Diabetes Mellitus
por: Li, Zelin, et al.
Publicado: (2021)

Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats
por: Lee, Ting-I, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sehesqsbtvsflej3qle0ukvqlb